Skip to main content

The Global Market for Marine Biotechnology: The Underwater World of Marine Biotech Firms

  • Chapter
  • First Online:
Grand Challenges in Marine Biotechnology

Abstract

Despite the increasing attention that political and institutional spheres are paying to marine biotechnology at a regional, national, and international level, also considering the Blue Growth Strategy in Horizon 2020, the general knowledge about private organizations of this field remains relatively poor. Actually, just a few studies offer an exhaustive picture of the companies developing products and services of both marine and freshwater origin. The authors wish to present an up-to-date analysis of the scientific and institutional literature concerned with the issue. They shall try to define blue biotechnology, and they will present the main markets served and their dynamics. In particular, cosmetic, pharmaceutical, nutraceutical, energy, and biochemical industries will be closely considered. Marine industrial sectors, actually, did not follow the same process of growth and show different levels of development. The aim of this chapter is to present the characteristics of the firms involved in blue biotechnology, describing both products and services that reach the final markets and highlighting the ones that are still at a development stage. The authors carried out a first investigation of the organizations belonging to the marine industries through the construction of an original dataset of companies. They analyzed geographical distribution, dimension, main markets served, and production activities of the firms in object. In the conclusions, the authors highlight the central role played by public research centers, the need for cooperation for blue biotechnology organizations in order to reach the final consumer, and the interdependence of research and development phases among the several businesses in which marine biotechnologies find industrial application.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Cited in Elvidge S. [1], “Bioprospecting at the poles”, Chemistry and Industry, Natural products, pp. 17–19.

  2. 2.

    Shreeve J. [2], “Craig Venter’s Epic Voyage to Redefine the Origin of the Species”, Wired, August.

  3. 3.

    http://science.sciencemag.org/content/348/6237

  4. 4.

    EU, DG Internal Policies, “Ocean Research in Horizon 2020: The Blue Growth Potential”, 2015. http://www.europarl.europa.eu/RegData/etudes/STUD/2015/518775/IPOL_STU(2015)518775_EN.pdf

  5. 5.

    cordis.europa.eu/programme/rcn/11852_en.html

  6. 6.

    It is to underline that the term “blue” has a wider meaning with respect to “marine,” as it considers industrial applications also of freshwater organisms. It is to stress, because often blue biotechnology is considered in reports on maritime policies or marine research centers.

  7. 7.

    http://biolume.net/entertainment/

  8. 8.

    http://www.slideshare.net/GlobalIndustryAnalystsInc/marine-biotechnology-a-global-strategic-business-report

  9. 9.

    http://www.smithersrapra.com/market-reports/biomaterials-industry-market-reports/the-future-of-marine-biotechnology-for-industrial

  10. 10.

    http://naturalproducts.pharmaceuticalconferences.com/events-list/marine-biotechnology

  11. 11.

    Ibidem.

  12. 12.

    http://www.bccresearch.com/market-research/pharmaceuticals/marine-derived-pharma-markets-phm101a.html

  13. 13.

    http://www.statista.com/statistics/243953/market-share-of-the-leading-10-beauty-companies-in-the-us/

  14. 14.

    http://www.shuuemura.com/_en/_ww/discover-shu-uemura/shu-uemura-timeline.aspx

  15. 15.

    http://www.biotherm.it/landing?fdid=activeIngredients

  16. 16.

    Cited in Elvidge S. [1], “Bioprospecting at the poles”, Chemistry and Industry, Natural products, pp. 17–19.

  17. 17.

    http://marinepharmacology.midwestern.edu/clinPipeline.htm

  18. 18.

    Quoted in “Thinking Blue: Addressing Today’s Challenges with Marine Biotechnology” (2012), BlueBio Project Report.

  19. 19.

    “Going Commercial. Algenol boosts yields, cuts costs for biofuel production”, Jerry Perkins, Biofuels Journal, 2° trimester 2014.

  20. 20.

    La bolla delle alghe, 9 aprile 2009, Nova, Sole24Ore.

    http://marinepharmacology.midwestern.edu/clinPipeline.htm

  21. 21.

    Defined by the sea: Nova Scotia’s Ocean Technology Sector present and future (2010).

  22. 22.

    Thinking Blue: Addressing Today’s Challenges with Marine Biotechnology (2012), Blue Bio Report.

  23. 23.

    Strategy for the marine biotechnology cluster in Tromso 2012–2015, Biotech North.

  24. 24.

    Seeing Purpose and Profiting Algae, New York Times.

  25. 25.

    BiomassAlternativeEnergy.Availableonlineat:www.prezi.com

  26. 26.

    Keywords were marine biotechnology, marine bioactive compounds, and marine biomaterial (firm, company).

  27. 27.

    What Happened to Biofuels (2013). The Economist, Technology Quarterly n.3, 7 September.

  28. 28.

    http://marinepharmacology.midwestern.edu/clinPipeline.htm

  29. 29.

    Keywords were marine biotechnology, marine bioactive compounds, and marine biomaterial (firm, company). The authors checked all the results of the first 15 pages.

  30. 30.

    www.environmental-expert.com, www.biomarine-resources.com, Algae fuel producers on en.wikipedia.org, www.cleantick.com/companies, www.ethanolproducer.com, biopharmguy.com, biomarine-resources.blogspot.it, www.oilgae.com, www.seao2.com/algaebiofuels, www.algaeu.com

  31. 31.

    https://worldwide.espacenet.com/

  32. 32.

    Patents’ portfolios could be, in some cases, undervalued. For Asian companies this could happen because of the non-perfect dialogue between the patent systems. In the case of start-ups and spin-offs, this could happen because the patents could be registered with the name of the inventor, not by the firm itself (so you lose the information).

  33. 33.

    http://www.forbes.com/sites/steveschaefer/2016/05/25/the-worlds-largest-companies-2016/%23;e3465fdc5524 and http://beta.fortune.com/global500/list

  34. 34.

    18th January 2017, Press Release, available at: http://news.exxonmobil.com/press-release/synthetic-genomics-and-exxonmobil-renew-algae-biofuels-research-agreement

  35. 35.

    Ibidem.

  36. 36.

    http://www.biolume.net/

  37. 37.

    http://www.olmix.com/human-care

  38. 38.

    Many companies have professors, scientists, and researchers that come from different public research centers, for example, and cannot be defined as spin-offs (of one organization). Still, several academics participate in the boards of direction of the firms.

  39. 39.

    An official statistical definition is not still available (NACE codes).

  40. 40.

    http://www.glycomarblog.com/

References

  1. Elvidge S (2011) Bioprospecting at the poles, Chemistry and industry, Natural products, pp 17–19

    Google Scholar 

  2. Shreeve J (2004) Craig Venter’s epic voyage to redefine the origin of the species. Wired, August. Available at: www.wired.com/2004/08/venter/

  3. Thorndyke M, Kloareg B, Canário AVM, Ribera d’Alcalà M, Johnston IA, Kooistra WHCF, Lister P, Serck-Hanssen T, Kervella A-E, Montenegro de Rynge Z, Pade N, Fuchs J, Fernandes S, Probert I (2013) EMBRC Business Plan

    Google Scholar 

  4. Hu G-P, Yuan J, Sun L, She Z-G, Wu J-H, Lan X-J, Zhu X, Lin Y-C, Chen S-P (2011) Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs 9:514–525. https://doi.org/10.3390/md9040514

    Article  PubMed  PubMed Central  Google Scholar 

  5. Leary D, Vierros M, Hamon G, Arico S, Monagle C (2009) Marine genetic resource: a review of scientific and commercial interest. Mar Policy 33:183–194. https://doi.org/10.1016/j.marpol.2008.05.010

    Article  Google Scholar 

  6. Martins A, Vieira H, Gaspar H, Santos S (2014) Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success. Mar Drugs 12:1066–1101. https://doi.org/10.3390/md12021066

    Article  PubMed  PubMed Central  Google Scholar 

  7. Murray MP et al (2013) Sustainable production of biologically active molecules of marine based origin. New Biotechnol 30:839–850. https://doi.org/10.1016/j.nbt.2013.03.006

    Article  CAS  Google Scholar 

  8. Greco GR, Cinquegrani M (2016) Firms plunge into the sea. marine biotechnology industry, a first investigation. Front Mar Sci 2:124. Available at: https://doi.org/10.3389/fmars.2015.00124

    Article  Google Scholar 

  9. Van Beuzekon B, Arundel A (2009) OECD biotechnology statistics, OECD Report. https://www.oecd.org/sti/42833898.pdf

  10. DaSilva EJ (2004) The colours of biotechnology: science, development and humankind. Electron J Biotechnol 7(3). Available at: http://www.scielo.cl/scielo.php?pid=S0717-34582004000300001&script=sci_arttext&tlng=e

  11. Boyen C, Jaouen P (2015) Les Biotechnologies dans le Grand Ouest, Europôle Mer ed. Available at: www.europolemer.eu/content/download/.../Biotech-Web.pdf

  12. Marine Cluster (2010) Provence-Alpes-Côte d’Azur, PoleMer Paca. Available at: https://webgate.ec.europa.eu/maritimeforum/sites/maritimeforum/files/Med%20clusters%20-%20Annexes%20def_0.pdf

  13. Marine Studies in Norway (2008) Norwegian Centre for International Cooperation in higher education (SIU). Available at: https://siu.no/.../Webversjon_endelig_Marine%20Studies.pdf

  14. The Importance of the Ocean Cluster for the Icelandic Economy (2012) Islandsbanki, Iceland Ocean cluster. Available at: skjol.islandsbanki.is/.../Sjavarklasinn_Skyrsla-enska-low.pdf

  15. Ernst&Young (2015a) Beyond borders. Reaching new heights, Biotechnology Industry Report. Available at: http://www.ey.com/Publication/vwLUAssetsPI/EY-beyond-borders-2015/#FILE/EY-beyond-borders-2015.pdf

  16. Deloitte (2017) Global life sciences outlook. Thriving in today’s uncertain market, Report. Available at: https://www2.deloitte.com/global/en/pages/life-sciences-and-healthcare/articles/global-life-sciences-sector-outlook.html

  17. Jaspars M, De Pascale D, Andersen JH, Reyes F, Crawford AD, Ianora A (2016) The marine biodiscovery pipeline and ocean medicine of tomorrow. J Mar Biol Assoc UK 96(1):151–158. Available at: https://doi.org/10.1017/S0025315415002106

    Article  Google Scholar 

  18. Kijjoa A, Sawangwong P (2004) Drugs and cosmetics from the sea. Mar Drugs 2:73–82. ISSN 1660-3397

    Article  CAS  PubMed Central  Google Scholar 

  19. Burgess J (2012) New and emerging analytical techniques for marine biotechnology. Curr Opin Biotechnol 23:29–33. https://doi.org/10.1016/j.copbio.2011.12.007

    Article  PubMed  CAS  Google Scholar 

  20. OECD (2013) Report marine biotechnology. Enabling solutions for ocean productivity and sustainability. Available at: http://www.oecd.org/greengrowth/marine-biotechnology-ocean-productivity-sustainability.htm

  21. DG Maritime Affairs and Fisheries (2014) Study in support of impact assessment work on blue biotechnology, Final Report FWC MARE. Available at: https://webgate.ec.europa.eu/maritimeforum/sites/maritimeforum/files/Blue%20Biotech%20-%20Final%20Report%20final.pdf

  22. Vigani M, Parisi C, Rodriguez-Cerezo E, Barbosa MJ, Sijtsma L, Ploeg M, Enzing C (2015) Food and feed products from micro-algae: market opportunities and challenges for the EU. Trends Food Sci Technol 42(1): 81–92. ISSN 0924-2244

    Article  CAS  Google Scholar 

  23. Kumar S (2005) Exploratory analysis of global cosmetic industry: major players, technology and market trends. Technovation 25:1263–1272. https://doi.org/10.1016/j.technovation.2004.07.003

    Article  Google Scholar 

  24. Ernst & Young (2015b) Seeking sustainable growth. The luxury and cosmetics financial factbook, Industry Report. Available at: http://www.ey.com/Publication/vwLUAssets/EY_Factbook_2015/$FILE/EY-Factbook-2015.PDF

  25. AT Kearney (2013) Beauty and personal care: industry disruptors and supply chain implications, Industry Report. Available at: http://www.atkearney.fr/operations/ideas-insights/article/-/asset_publisher/LCcgOeS4t85g/content/beauty-and-personal-care-industry-disruptors-and-supply-chain-implications/10192

  26. Eriksen-Stanley A (2013) Marine ingredients for the future of skin care, GCI, 24th August. Available at: http://www.gcimagazine.com/business/rd/ingredients/Marine-Ingredients-for-the-Future-of-Skin-Care-221259811.html

  27. Wang DH-M, Ching-Chun C, Huynh P, Chang J-S (2015) Exploring the potential of using algae in cosmetics. Bioresour Technol 184:355–362. https://doi.org/10.1016/j.biortech.2014.12.001

    Article  PubMed  CAS  Google Scholar 

  28. Kim SK (2013) Marine cosmeceuticals. J Cosmetic Dermatol 13:56–67

    Article  PubMed  Google Scholar 

  29. Deloitte (2016) Global life sciences outlook. Moving forward with cautious optimism. Report available at: https://www2.deloitte.com/content/dam/Deloitte/global/Documents/Life-Sciences-Health-Care/gx-lshc-2016-life-sciences-outlook.pdf

  30. EFPIA (2016) European Federation of Pharmaceutical Industries and Associations Report, The Pharmaceutical Industry in Figures. Available at: http://www.efpia.eu/uploads/Modules/Documents/the-pharmaceutical-industry-in-figures-2016.pdf

  31. Gautam A, Pan X (2015) The changing model of big pharma: impact of key trends. Drug Discov Today. https://doi.org/10.1016/j.drudis.2015.10.002

  32. Molinski TF, Dalisay DS, Lievens SL, Saludes JP (2009) Drug development from marine natural products. Nat Rev Drug Discov 8:69–85. https://doi.org/10.1038/nrd2487

    Article  PubMed  CAS  Google Scholar 

  33. Mayer A, Glaser K, Cuevas C, Jacobs R, Kem W, Little D, McIntosh M, Newman D, Potts B, Shuster D (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 31:255–265. https://doi.org/10.1016/j.tips.2010.02.005

    Article  PubMed  CAS  Google Scholar 

  34. Glaser KB, Mayer A (2009) A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Biochem Pharmacol 78:440–448. https://doi.org/10.1016/j.bcp.2009.04.015

    Article  PubMed  CAS  Google Scholar 

  35. KPMG International (2015) Nutraceuticals: the future of intelligent food – where food and pharmaceuticals converge. Available at: https://www.kpmg.com/ID/en/industry/CM/Documents/neutraceuticals-the-future-of-intelligent-food.pdf

  36. Frost&Sullivan and FICCI Report (2011) Global nutraceutical industry: investing in healthy living. Available at: http://www.frost.com/prod/servlet/cio/236145272

  37. Enzing C, Ploeg M, Barbosa M, Sijtsma L (2014) Microalgae-based products for the food and feed sector: an outlook for Europe, JRC Scientific and Policy Reports. Available at: http://ftp.jrc.es/EURdoc/JRC85709.pdf

  38. IEA Bioenergy Report (2017) State of technology review – Algae bioenergy. Inter-task Strategic Project, Task 39. Available at: http://www.ieabioenergy.com/wp-content/uploads/2017/01/IEA-Bioenergy-Algae-report-update-20170114.pdf

  39. Runge W (2014) Technology entrepreneurship: a treatise on entrepreneurs and entrepreneurship for and in technology ventures. KIT Scientific Publishing. ISBN:3731501082, 9783731501084. Available at: https://books.google.it/books?id=uMcVBAAAQBAJ&dq=appendix+a+biofules+bubble+outburst+microalgae&hl=it&source=gbs_navlinks_s

  40. IEA Bioenergy report (2013) Bio-based chemicals. Value added products from biorefineries, Task 42. Available at: http://www.ieabioenergy.com/wp-content/uploads/2013/10/Task-42-Biobased-Chemicals-value-added-products-from-biorefineries.pdf

  41. OECD (2009) The bioeconomy to 2030, designing a policy agenda. Available at: www.oecd.org/publishing/corrigenda

  42. Golden JS, Handfield RB (2014) Why bio-based. Opportunities in the emerging bioeconomy, Duke University Report. Available at: https://www.biopreferred.gov/files/WhyBiobased.pdf

  43. Cassell C, Symon G (1994) Qualitative methods in organizational research: a practical guide. Sage, London

    Google Scholar 

  44. Atlantic Canada Opportunities Agency (2003) Biotechnology in Atlantic Canada. Available at: http://www.releases.gov.nl.ca/releases/2003/itrd/0620n03.htm

  45. Brar B, McLarney C (2001) Poised for success? An analysis of the Halifax Biotechnology Cluster, Halifax, Canada: the Centre for International Trade and Transportation. CITT discussion paper no. 187

    Google Scholar 

  46. European Science Foundation (2001) Marine biotechnology. A European strategy for marine biotechnology, Marine Board, Position Paper n. 4

    Google Scholar 

  47. Sea Grant Florida (2004) The promise of marine biotechnology in Florida. Available at: http://nsgl.gso.uri.edu/flsgp/flsgpq04004.pdf

  48. InterMarec—Interregional Maritime Cluster: The Benefit of Interregional Cooperation (2007) Booklet INTERREG IIIC

    Google Scholar 

  49. National Research Council (2002) Marine biotechnology in the XXI century. Problems, promise and products, Ocean Studies Board, National Academy Press

    Google Scholar 

  50. Carlberg A (2012) The marine cluster in Västra Götaland, Västra Götalands Regionen

    Google Scholar 

  51. Cooke P, Porter J, Cruz AR, Pinto H (2011) Maritime clusters – institutions and innovation actors in the Atlantic area, Editor-University of Algarve

    Google Scholar 

  52. Delving Deeper (2012) A new era for marine collaboration. Int Innovation Environ, October

    Google Scholar 

  53. Ellingsen M, Tromso N (2010) Innovation in marine biotechnology: clustering or trust and entrepreneurship? An explorative study of an issuant industry in the high north, paper presented at 5th international seminar on regional innovation policies, 14–15 Oct 2010, Grimstad

    Google Scholar 

  54. Germany Trade & Invest (2010) BioRegions in Germany

    Google Scholar 

  55. Lundquist TJ, Woertz IC, Quinn NWT, Benemann JR (2010) A realistic technology and engineering assessment of algae biofuel production. Energy Biosciences Institute

    Google Scholar 

  56. Maritime Clusters in Västra Götaland (2013) Region Västra Götaland. University of Gothenburg, Gothenburg

    Google Scholar 

  57. NC Biotechnology Center (2013) Biorenewable and Biotechnology Asset Inventory in North Carolina’s Southeast Region

    Google Scholar 

  58. NetAlgae Project (2012) Seaweed industry in France (2012), Pôle Halieutique Agrocampus Ouest

    Google Scholar 

  59. Nordwest-Verbund Meeresforschung (2010) Marine technology. Research and transfer

    Google Scholar 

  60. Norgenta and DSN Analysen & Strategien (2012) Marine biotechnology Schleswig-Holstein. A regional development strategy

    Google Scholar 

  61. European Science Foundation (2010) Marine biotechnology: a new vision and strategy for Europe, Marine board, Position Paper n 15

    Google Scholar 

  62. Rappert B, Webster A, Charles D (1999) Making sense of diversity and reluctance: academic-industrial relations and intellectual property. Res Policy 28:873–890

    Article  Google Scholar 

  63. Allen MJ, Jaspars M (2009) Realizing the potential of marine biotechnology. Challenges and opportunities. Ind Biotechnol 5:77–80

    Article  Google Scholar 

  64. Raghukumar S (2011) Marine biotechnology: an approach based on components, levels and players. Ind J Geo Mar Sci 40:609–619. https://www.researchgate.net/publication/279555791_Marine_biotechnology_An_approach_based_on_components_levels_and_players

Download references

Acknowledgments

The authors wish to thank the Flagship Program “Ritmare” for the financial support. The work is in fact an output of the activity on technology transfer of the project (SP6_WP4_AZ1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gaia Raffaella Greco .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Greco, G.R., Cinquegrani, M. (2018). The Global Market for Marine Biotechnology: The Underwater World of Marine Biotech Firms. In: Rampelotto, P., Trincone, A. (eds) Grand Challenges in Marine Biotechnology. Grand Challenges in Biology and Biotechnology. Springer, Cham. https://doi.org/10.1007/978-3-319-69075-9_8

Download citation

Publish with us

Policies and ethics